Lack of Cardiotoxicity Endpoints in Prospective Trials Involving Chest Radiation Therapy: A Review of Registered, Latter-Phase Studies is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: K23 HL155890
NHLBI NIH HHS
Grant: R01 HL170038
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 5K23HL155890-02
Early Detection and Mechanisms of Cancer Immunotherapy Associated Cardiotoxicity
National Institutes of Health
Grant: 2K12CA133250-16
OSU K12 Training Grant in Oncology
FWCI
0.62
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals